arrow
A

Aleksandar Sekulić

Mayo Clinic
H指数:35
被引数:8,191

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiomic Sequencing of Intermediate- to High-Risk Cutaneous Squamous Cell Carcinoma Identifies Critical Genes and Expression Patterns Associated with Disease and Poor Outcomes

多组学测序分析中危至高危皮肤鳞状细胞癌,鉴定与疾病及不良预后相关的关键基因和表达模式

2025-01-280
PRE
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
2024-02-017
OA
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up
2024-02-014
OAAI
Basal Cell Skin Cancer, Version 2.2024
2023-11-0122
OA
Universal genetic testing for hereditary cancer syndromes in an under-represented minority population
2023-04-041
PRE
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
2023-01-1118
OA
Squamous Cell Skin Cancer, Version 1.2022 Featured Updates to the NCCN Guidelines
2021-12-0173
OA
Primary analysis of phase II results for cemiplimab in patients (pts) with locally advanced basal cell carcinoma (laBCC) who progress on or are intolerant to hedgehog inhibitors (HHIs)
2020-09-0111
OAAI
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials

黑色素瘤的化学预防剂: 进入3期临床试验的途径

CANCER
IF5.1
2018-10-0321
OAAI